Wenger Plattner handles strategic mergers and acquisitions as well as divestitures across a broad array of sectors in the pharmaceutical, IT, retail, real estate and automotive sectors. Oliver Künzler spearheads the team and handles the entire spectrum of M&A, reorganisations, PE and venture capital transactions. Urs Reinwald counsels entrepreneurs, investors, start-ups, SMEs and public companies on a broad range of matters. Managing partner Marc Nater also comes recommended.
Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • ‘Direct communication with clear and good understanding. Independently does what is necessary and has clear boundaries and pragmatic proposals for solutions. Experienced negotiator who understands not only the legal side but also the business side.’
  • ‘This practice stands out for its client-focused approach, combining deep legal expertise with pragmatic, solution-oriented advice. Compared to other firms, the practice distinguishes itself through close partner involvement and seamless teamwork.’
  • ‘The individuals I work with stand out for their exceptional commitment, strategic insight and their ability to translate complex legal issues into practical solutions. I particularly value their responsiveness, clear communication and strong client care.’

Key clients

  • Audi AG
  • Novartis Pharma Ltd.
  • Sauber Group
  • Julius Baer Group
  • BACHEM
  • SWICA Gesundheitsorganisation
  • AUDAX Private Equity
  • Starcom Group
  • Sun Hung Kai & Co. Limited
  • LSG Lufthansa Service Holding
  • Corden Pharma
  • Neovii Pharmaceuticals AG

Work highlights

Advised AUDI with respect to its entry in Formula 1 via the takeover of 75% of the shares of Formula 1 team Sauber.
Advised the Saurer Group on all Swiss legal aspects of the sale of three business units to Rieter, at a value of CHF300m.
Advised Corden Pharma on the creation of a new Swiss subsidiary.
Practice head

Oliver Künzler

Other key lawyers

Urs Reinwald; Marc Nater